J&J says its psoriasis drug superior to Novartis treatment in study

  • 📰 Reuters
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 97%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Johnson & Johnson said its drug, Tremfya, was found to be more effective than a ...

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Knowing Johnson & Johnson it should be better than most.

For about $60,000 a year. Obscene.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 2. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

A top Novartis executive says the $225 billion drug giant is planning for a 'doomsday scenario' in cancer treatmentPharma giant Novartis is developing drugs that could prevent cancer before patients get it. One big question: how will we pay for them?
Source: BusinessInsider - 🏆 729. / 51 Read more »

Diet drugs could halt mosquitoes' blood-sucking behavior, study saysBy giving mosquitoes diet drugs, they could be prevented from biting humans and spreading deadly diseases, according to new research
Source: CNN - 🏆 4. / 95 Read more »

Novartis Seeks Growth in Newer Drugs Amid Pricing ChallengesThe Swiss health care giant said it expected sales to grow by a mid-single digit percentage in 2019, even though it is likely to have to cut the prices of its drugs.
Source: WSJ - 🏆 98. / 63 Read more »

J&J raises US prices on around two dozen drugsJohnson & Johnson raised U.S. prices on around two dozen prescription drugs on Thursday, including the psoriasis treatment Stelara, prostate cancer drug Zytiga and blood thinner Xarelto, all among its top-selling products. Cela devient hors de prix de se soigner ! C'est écoeurant !
Source: CNBC - 🏆 12. / 72 Read more »

This gene therapy treatment for blindness is the most expensive drug in AmericaLuxturna is a groundbreaking new drug that’s a one-time treatment to restore sight. The CEO says the $850,000 price tag is based on what juries have awarded someone who’s been blinded, but an independent watchdog group calls the drug overpriced. Who the hell can afford $850,000?!? Stupid drug companies!! Is the devil working there?!😕 Is the devil more good hearted than drug companies?!😕 People can die from the stupidity of the price....
Source: NBCNews - 🏆 10. / 86 Read more »

The digital drug: Internet addiction spawns U.S. treatment programsWhen Danny Reagan was 13, he began exhibiting signs of what doctors usually asso... I’m sorry but can we not trivialize the hell out of a serious medical program by lumping “internet addiction” in the same category as actual addiction, to heroin or alcohol or cocaine? Just say, “Know.”. WHITE privilege.
Source: Reuters - 🏆 2. / 97 Read more »